Monaco vs USSR: Life science patents granted, by filing office
Monaco
1 patents
in 2023
USSR
0 patents
in 2023
Monaco rank
46th
USSR rank
48th
Life science patents granted, by filing office over time
- Monaco
- USSR
How they compare
Monaco currently reports 1 patents against 0 patents in USSR, a difference of 1 patents.
The two have swapped places 13 times across 44 shared years of data; in 1980 it was USSR ahead.
Monaco ranks 46th and USSR ranks 48th of 70 countries.
Across the 5 decades both report, Monaco averaged higher in 3 and USSR in 2.
Head to head by decade
| Decade | Monaco | USSR | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 16.1 patents | 2,200 patents | 2,184 patents | USSR |
| 1990s | 7.3 patents | 636.5 patents | 629.2 patents | USSR |
| 2000s | 1.1 patents | 0 patents | 1.1 patents | Monaco |
| 2010s | 1.1 patents | 0 patents | 1.1 patents | Monaco |
| 2020s | 1 patents | 0 patents | 1 patents | Monaco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by filing office, Monaco or USSR?
- Monaco, at 1 patents against 0 patents in USSR as of 2023.
- What is the difference in life science patents granted, by filing office between Monaco and USSR?
- 1 patents, with Monaco ahead.
- How many years of comparable data are there for Monaco and USSR?
- 44 years are reported by both, from 1980 to 2023.
- How do Monaco and USSR rank globally for life science patents granted, by filing office?
- Monaco ranks 46th and USSR ranks 48th of 70 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data, published as Life science patents granted, by filing office. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Patents granted within the fields of medical technology, biotechnology, and pharmaceuticals by filing office. These patents cover a wide range of innovations, such as medical devices, diagnostic methods, genetic engineering techniques, biotechnological processes and new drugs.